About TriSalus Life Sciences
TriSalus Life Sciences (NASDAQ:TLSIW) focuses on transforming the way solid tumor cancers are treated, with a keen emphasis on pancreatic and liver cancers. The company is committed to improving patient outcomes by integrating Pressure-Enabled Drug Delivery (PEDD) with immunotherapies to overcome the physical barriers that have historically limited effective treatment delivery to solid tumors. TriSalus’s operations are deeply rooted in innovation and research, aiming to develop therapies that can make a significant difference in patients’ lives. Their projects include advanced clinical trials and the development of proprietary drug delivery technologies designed to enhance the efficacy of existing cancer treatments. The objective of TriSalus is not only to extend the lifespan but also to improve the quality of life for patients fighting these challenging diseases.
Snapshot
Operations
Products and/or services of TriSalus Life Sciences
- Pressure-Enabled Drug Delivery (PEDD) technology, enhancing the delivery and effectiveness of therapies directly into solid tumors.
- SD-101, an investigational toll-like receptor 9 agonist, stimulating the immune system to fight cancer.
- Immuno-oncology programs, leveraging PEDD to advance treatments for liver and pancreatic cancers.
- Proprietary Pressure-Enabled Regional Immuno-Oncology (PERIO) approach, aimed at converting cold tumors to hot, making them more treatable.
- Partnerships for developing drug delivery platforms, combining PEDD with partners' drugs for improved outcomes.
- Clinical trials focused on safety and efficacy of PEDD in combination with other therapies for treating solid tumors.
TriSalus Life Sciences executive team
- Ms. Mary T. Szela B.S.N., M.B.A.CEO, President & Director
- Mr. Sean Edward MurphyChief Manufacturing, Strategy & Business Development Officer and Director
- Mr. James E. YoungChief Financial Officer
- Ms. Lori Ann SantamariaVice President of Operations
- Ms. Jennifer L. Stevens J.D.Chief Regulatory Officer
- Dr. Richard B. Marshak M.B.A., MBA, VMDChief Commercial Officer
- Ms. Jodi DevlinChief of Clinical Strategy & Operations
- Dr. Bryan F. Cox Ph.D.Chief of Research